In silico studies of quinazolinone analogues to distinguish their hypothetical binding mode using the X-ray crystal structure human carbon anhydrase II (HCAII) enzyme complex with sugar sulfamate for anticonvulsant activity. Int. J. Pharm. Sci. Drug Res. [Internet]. 2023 Sep. 30 [cited 2025 Oct. 16];15(5):675-9. Available from: https://ijpsdronline.com/index.php/journal/article/view/7968